Standout Papers
- SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7 (2002)
- Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542 (2002)
Immediate Impact
10 by Nobel laureates 18 from Science/Nature 73 standout
Citing Papers
A pulsatile release platform based on photo-induced imine-crosslinking hydrogel promotes scarless wound healing
2021 Standout
Immunomodulation‐Enhanced Nanozyme‐Based Tumor Catalytic Therapy
2020 Standout
Works of Nicholas J. Laping being referenced
SB-505124 Is a Selective Inhibitor of Transforming Growth Factor-β Type I Receptors ALK4, ALK5, and ALK7
2004
Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)
2002
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nicholas J. Laping | 3651 | 978 | 598 | 717 | 82 | 6.2k | |
| Teresa L. Wood | 2430 | 783 | 398 | 647 | 111 | 5.0k | |
| Alastair D. Reith | 4526 | 652 | 828 | 922 | 52 | 7.0k | |
| Ali Hafezi‐Moghadam | 2526 | 844 | 614 | 382 | 94 | 6.5k | |
| Steven G. Kernie | 2475 | 854 | 657 | 1632 | 79 | 6.7k | |
| Zengqiang Yuan | 5118 | 743 | 907 | 704 | 135 | 8.0k | |
| Brian Harding | 2802 | 1031 | 512 | 901 | 156 | 6.7k | |
| Masakiyo Sasahara | 2036 | 578 | 589 | 641 | 144 | 5.2k | |
| Ping Wei | 1623 | 1014 | 568 | 1292 | 119 | 5.9k | |
| Neeraj Agarwal | 3574 | 505 | 322 | 964 | 113 | 5.1k | |
| Kiyofumi Asai | 2183 | 751 | 410 | 634 | 160 | 4.2k |
All Works
Loading papers...